Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Novartis
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT02088684
First received: March 12, 2014
Last updated: September 9, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2019
  Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)